SectorPharmaceutical
Established Date08/09/2011
Listing Date10/02/2014
ExchangeNASDAQ Stock Exchange
Full-time Employees6
Fiscal Year Ends31/12
Security TypeCommon stock
Office address411 Swedeland Road
Suite 23-1080
King of Prussia
PA 19406
Business
IntroductionPhio Pharmaceuticals Corp. was incorporated in Delaware on September 8, 2011. Phio is a clinical-stage biopharmaceutical company that utilizes its proprietary INTASYL small interfering RNA gene silencing technology to enhance the effectiveness of immune cells to target and destroy tumor cells. The company is committed to developing therapies that use INTASYL technology to specifically target proteins that inhibit the body's anti-cancer ability, without relying on special preparations or drug delivery systems. Dedicated to the discovery and development of innovative cancer therapies, Phio Pharmaceuticals aims to open new avenues to a cancer-free future. The company adopts the model of a single operating department and a single reporting department.
